In theory, restoring miR-532 levels in cancer would suppress oncogenic E2F1 expression, which in turn would weaken the inhibition of miR-532, thereby promoting the accumulation of miR-532 in cancer cells and delaying tumor growth. Here, E2F1 is linked to cancer.